Kayitalire Louis

CIK 00018315191 companyCAMBRIDGE, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001831519

Recent Transactions

17 trades

Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−12,880→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−35,719→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−27,289→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−53,634→ 0 total
Disposition from Tender
F-star Therapeutics, Inc.
Common Stock
2023-03-08$7.12/sh−29,236→ 25,019 total
Disposition to Issuer
F-star Therapeutics, Inc.
Common Stock
2023-03-08$7.12/sh−25,019→ 0 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2022-03-31+35,719→ 35,719 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2022-01-09+53,634→ 53,634 total
Sale
F-star Therapeutics, Inc.
Common Stock
2021-11-02$6.81/sh−39→ 54,280 total
Sale
F-star Therapeutics, Inc.
Common Stock
2021-11-02$6.85/sh−25→ 54,255 total
Sale
F-star Therapeutics, Inc.
Common Stock
2021-10-04$7.23/sh−64→ 54,319 total
Sale
F-star Therapeutics, Inc.
Common Stock
2021-07-02$8.43/sh−1,054→ 54,383 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2021-03-09+12,880→ 40,169 total
Award
F-star Therapeutics, Inc.
Common Stock
2021-02-01+29,000→ 55,437 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20+27,289→ 27,289 total
Award
F-star Therapeutics, Inc.
Common Stock
2020-11-20+26,437→ 26,437 total
Award
F-star Therapeutics, Inc.
Restricted Stock Units
2020-11-20+26,437→ 26,437 total

Companies

F-star Therapeutics, Inc.
Chief Medical Officer

Recent Filings

Address

C/O F-STAR THERAPEUTICS, INC. EDDEVA B920, BABRAHAM RESEARCH CAMPUS

CAMBRIDGE, X0, CB22 3AT

View on SEC.gov